Adams, P.D., Afonine, P.V., Bunko´ czi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010). PHENIX: a comprehensive Python-based system for macromolecular struc- ture solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213–221.
Afonine, P.V., Poon, B.K., Read, R.J., Sobolev, O.V., Terwilliger, T.C., Urzhumtsev, A., and Adams, P.D. (2018). Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D Struct. Biol. 74, 531–544.
Audet, M., and Stevens, R.C. (2019). Emerging structural biology of lipid G pro- tein-coupled receptors. Protein Sci. 28, 292–304.
Audet, M., White, K.L., Breton, B., Zarzycka, B., Han, G.W., Lu, Y., Gati, C., Batyuk, A., Popov, P., Velasquez, J., et al. (2019). Crystal structure of miso- prostol bound to the labor inducer prostaglandin E2 receptor. Nat. Chem. Biol. 15, 11–17.
Bao, X., Albu, D., Huang, K.-C., Wu, J., Twine, N., Nomoto, K., and Woodall- Jappe, M. (2015). Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models. J. Immunother. Cancer 3, P350.
Bastien, L., Sawyer, N., Grygorczyk, R., Kathleen, M.M., and Adam, M. (1994). Cloning, functional expression, and characterization of the human prosta- glandin E, receptor EP2 subtype. J. Biol. Chem. 269, 11873–11877.
Cao, C., Tan, Q., Xu, C., He, L., Yang, L., Zhou, Y., Zhou, Y., Qiao, A., Lu, M., Yi, C., et al. (2018). Structural basis for signal recognition and transduction by platelet-activating-factor receptor. Nat. Struct. Mol. Biol. 25, 488–495.
Carpenter, B., and Tate, C.G. (2016). Engineering a minimal G protein to facil- itate crystallisation of G protein-coupled receptors in their active conformation. Protein Eng. Des. Sel. 29, 583–593.
Chrencik, J.E., Roth, C.B., Terakado, M., Kurata, H., Omi, R., Kihara, Y., Warshaviak, D., Nakade, S., Asmar-Rovira, G., Mileni, M., et al. (2015). Crystal structure of antagonist bound human lysophosphatidic acid receptor 1. Cell 161, 1633–1643.
Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., Murray, L.W., Arendall, W.B., Snoeyink, J., Richardson, J.S., et al. (2007). MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, 375–383.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126–2132.
Fan, H., Chen, S., Yuan, X., Han, S., Zhang, H., Xia, W., Xu, Y., Zhao, Q., and Wu, B. (2019). Structural basis for ligand recognition of the human throm- boxane A2 receptor. Nat. Chem. Biol. 15, 27–33.
Fujino, H., and Regan, J.W. (2006). EP 4 prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol. Pharmacol. 69, 5–10.
Garcı´a-Nafrı´a, J., Lee, Y., Bai, X., Carpenter, B., and Tate, C.G. (2018). Cryo- EM structure of the adenosine A2A receptor coupled to an engineered hetero- trimeric G protein. eLife 7, e35946.
Gilman, A.G. (1987). G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615–649.
Goddard, T.D., Huang, C.C., Meng, E.C., Pettersen, E.F., Couch, G.S., Morris, J.H., and Ferrin, T.E. (2018). UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25.
Guan, Y., Stillman, B.A., Zhang, Y., Schneider, A., Saito, O., Davis, L.S., Redha, R., Breyer, R.M., and Breyer, M.D. (1996). Cloning and expression of the rabbit prostaglandin EP4 receptor. Am. J. Physiol. 270, F485–F493.
Gusach, A., Luginina, A., Marin, E., Brouillette, R.L., Besserer-Offroy, E´ ., Longpre´ , J.M., Ishchenko, A., Popov, P., Patel, N., Fujimoto, T., et al. (2019). Structural basis of ligand selectivity and disease mutations in cysteinyl leuko- triene receptors. Nat. Commun. 10, 5573.
Hanson, M.A., Roth, C.B., Jo, E., Griffith, M.T., Scott, F.L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S.M., Schuerer, S.C., et al. (2012). Crystal structure of a lipid G protein-coupled receptor. Science 335, 851–855.
Hirata, T., and Narumiya, S. (2011). Prostanoid receptors. Chem. Rev. 111, 6209–6230.
Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., and Ichikawa, A. (1993). Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268, 7759–7762.
Hori, T., Okuno, T., Hirata, K., Yamashita, K., Kawano, Y., Yamamoto, M., Hato, M., Nakamura, M., Shimizu, T., Yokomizo, T., et al. (2018). Na+- mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1. Nat. Chem. Biol. 14, 262–269.
Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G.W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016). Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750–762.e14.
Hua, T., Vemuri, K., Nikas, S.P., Laprairie, R.B., Wu, Y., Qu, L., Pu, M., Korde, A., Jiang, S., Ho, J.H., et al. (2017). Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547, 468–471.
Hua, T., Li, X., Wu, L., Iliopoulos-Tsoutsouvas, C., Wang, Y., Wu, M., Shen, L., Johnston, C.A., Nikas, S.P., Song, F., et al. (2020). Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures. Cell 180, 655–665.e18.
Inoue, A., Ishiguro, J., Kitamura, H., Arima, N., Okutani, M., Shuto, A., Higashiyama, S., Ohwada, T., Arai, H., Makide, K., et al. (2012). TGFa shedding assay: an accurate and versatile method for detecting GPCR activation. Nat. Methods 9, 1021–2029.
Inoue, A., Raimondi, F., Kadji, F.M.N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019). Illuminating G-protein- coupling selectivity of GPCRs. Cell 177, 1933–1947.e25.
Kumar, K.K., Shalev-Benami, M., Robertson, M.J., Hu, H., Banister, S.D., Hollingsworth, S.A., Latorraca, N.R., Kato, H.E., Hilger, D., Maeda, S., et al. (2019). Structure of a signaling cannabinoid receptor 1-G protein complex. Cell 176, 448–458.e12.
Lin, X., Li, M., Wang, N., Wu, Y., Luo, Z., Guo, S., Han, G.W., Li, S., Yue, Y., Wei, X., et al. (2020). Structural basis of ligand recognition and self-activation of orphan GPR52. Nature 579, 152–157.
Luginina, A., Gusach, A., Marin, E., Mishin, A., Brouillette, R., Popov, P., Shiriaeva, A., Besserer-Offroy, E´ ., Longpre´ , J.M., Lyapina, E., et al. (2019). Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci. Adv. 5, 2518.
Morimoto, K., Suno, R., Hotta, Y., Yamashita, K., Hirata, K., Yamamoto, M., Narumiya, S., Iwata, S., and Kobayashi, T. (2019). Crystal structure of the endogenous agonist-bound prostanoid receptor EP3. Nat. Chem. Biol. 15, 8–10.
Nehme´ , R., Carpenter, B., Singhal, A., Strege, A., Edwards, P.C., White, C.F., Du, H., Grisshammer, R., and Tate, C.G. (2017). Mini-G proteins: novel tools for studying GPCRs in their active conformation. PLoS One 12, e0175642.
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612.
Rasmussen, S.G.F., Devree, B.T., Zou, Y., Kruse, A.C., Chung, K.Y., Kobilka, T.S., Thian, F.S., Chae, P.S., Pardon, E., Calinski, D., et al. (2011). Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477, 549–555.
Rausch-Derra, L., Huebner, M., Wofford, J., and Rhodes, L. (2016). A prospec- tive, randomized, masked, placebo-controlled multisite clinical study of grapi- prant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoar- thritis. J. Vet. Intern. Med. 30, 756–763.
Rohou, A., and Grigorieff, N. (2015). CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221.
Sando, T., Usui, T., Tanaka, I., Mori, K., Sasaki, Y., Fukuda, Y., Namba, T., Sugimoto, Y., Ichikawa, A., Narumiya, S., et al. (1994). Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype. Biochem. Biophys. Res. Commun. 200, 1329–1333.
Schorb, M., Haberbosch, I., Hagen, W.J.H., Schwab, Y., and Mastronarde, D.N. (2019). Software tools for automated transmission electron microscopy. Nat. Methods 16, 471–477.
Shao, Z., Yin, J., Chapman, K., Grzemska, M., Clark, L., Wang, J., and Rosenbaum, D.M. (2016). High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature 540, 602–606.
Su, M., Zhu, L., Zhang, Y., Paknejad, N., Dey, R., Huang, J., Lee, M.-Y., Williams, D., Jordan, K.D., Eng, E.T., et al. (2020). Structural basis of the acti- vation of heterotrimeric Gs-protein by isoproterenol-bound b1-adrenergic re- ceptor. Mol. Cell. 80, 59–71.e4.
Taniguchi, R., Inoue, A., Sayama, M., Uwamizu, A., Yamashita, K., Hirata, K., Yoshida, M., Tanaka, Y., Kato, H.E., Nakada-Nakura, Y., et al. (2017). Structural insights into ligand recognition by the lysophosphatidic acid recep- tor LPA6. Nature 548, 356–360.
Toyoda, Y., Morimoto, K., Suno, R., Horita, S., Yamashita, K., Hirata, K., Sekiguchi, Y., Yasuda, S., Shiroishi, M., Shimizu, T., et al. (2019). Ligand bind- ing to human prostaglandin E receptor EP4 at the lipid-bilayer interface. Nat. Chem. Biol. 15, 18–26.
Trzaskowski, B., Latek, D., Yuan, S., Ghoshdastider, U., Debinski, A., and Filipek, S. (2012). Action of molecular switches in GPCRs—theoretical and experimental studies. Curr. Med. Chem. 19, 1090–1109.
Wang, L., Yao, D., Deepak, R.N.V.K., Liu, H., Xiao, Q., Fan, H., Gong, W., Wei, Z., and Zhang, C. (2018). Structures of the human PGD2 receptor CRTH2 reveal novel mechanisms for ligand recognition. Mol. Cell. 72, 48–59.
Ward, C.L., Jamieson, V., Nabata, T., Sharpe, J., Dozono, K., Suto, F., Hashimoto, Y., and Gussak, I. (2016). First clinical experience with ONO- 4232: a randomized, double-blind, placebo-controlled healthy volunteer study of a novel lusitropic agent for acutely decompensated heart failure. Clin. Ther. 38, 1109–1121.
Watanabe, Y., Murata, T., Amakawa, M., Miyake, Y., Handa, T., Konishi, K., Matsumura, Y., Tanaka, T., and Takeuchi, K. (2015). KAG-308, a newly-iden- tified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. Eur. J. Pharmacol. 754, 179–189.
Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T., and Ishikawa, Y. (2013). The prostanoid EP4 receptor and its signaling pathway. Pharmacol. Rev. 65, 1010–1052.
Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., Yamaguchi, K., Segi, E., Tsuboyama, T., Matsushita, M., et al. (2002). Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. U S A 99, 4580–4585.
Zhang, Y., Yang, F., Ling, S., Lv, P., Zhou, Y., Fang, W., Sun, W., Zhang, L., Shi, P., and Tian, C. (2020). Single-particle cryo-EM structural studies of the b2AR- Gs complex bound with a full agonist formoterol. Cell Discov. 6, 45.
Zivanov, J., Nakane, T., Forsberg, B.O., Kimanius, D., Hagen, W.J.H., Lindahl, E., and Scheres, S.H.W. (2018). New tools for automated high-resolution cryo- EM structure determination in RELION-3. Elife 7, e42166.
論文の公開元へ
